1. Home
  2. SLGL vs MAGH Comparison

SLGL vs MAGH Comparison

Compare SLGL & MAGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLGL
  • MAGH
  • Stock Information
  • Founded
  • SLGL 1997
  • MAGH 2012
  • Country
  • SLGL Israel
  • MAGH Singapore
  • Employees
  • SLGL N/A
  • MAGH N/A
  • Industry
  • SLGL Biotechnology: Pharmaceutical Preparations
  • MAGH Engineering & Construction
  • Sector
  • SLGL Health Care
  • MAGH Industrials
  • Exchange
  • SLGL Nasdaq
  • MAGH Nasdaq
  • Market Cap
  • SLGL 49.4M
  • MAGH 51.8M
  • IPO Year
  • SLGL 2018
  • MAGH 2025
  • Fundamental
  • Price
  • SLGL $23.48
  • MAGH $1.32
  • Analyst Decision
  • SLGL Buy
  • MAGH
  • Analyst Count
  • SLGL 1
  • MAGH 0
  • Target Price
  • SLGL $40.00
  • MAGH N/A
  • AVG Volume (30 Days)
  • SLGL 30.1K
  • MAGH 994.9K
  • Earning Date
  • SLGL 08-15-2025
  • MAGH 01-01-0001
  • Dividend Yield
  • SLGL N/A
  • MAGH N/A
  • EPS Growth
  • SLGL N/A
  • MAGH N/A
  • EPS
  • SLGL N/A
  • MAGH 0.03
  • Revenue
  • SLGL $23,931,000.00
  • MAGH $13,529,576.00
  • Revenue This Year
  • SLGL N/A
  • MAGH N/A
  • Revenue Next Year
  • SLGL $31.17
  • MAGH N/A
  • P/E Ratio
  • SLGL N/A
  • MAGH $42.55
  • Revenue Growth
  • SLGL 264.86
  • MAGH 10.71
  • 52 Week Low
  • SLGL $4.01
  • MAGH $1.00
  • 52 Week High
  • SLGL $26.89
  • MAGH $5.15
  • Technical
  • Relative Strength Index (RSI)
  • SLGL 72.14
  • MAGH N/A
  • Support Level
  • SLGL $20.06
  • MAGH N/A
  • Resistance Level
  • SLGL $26.89
  • MAGH N/A
  • Average True Range (ATR)
  • SLGL 2.57
  • MAGH 0.00
  • MACD
  • SLGL 0.63
  • MAGH 0.00
  • Stochastic Oscillator
  • SLGL 75.10
  • MAGH 0.00

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About MAGH Magnitude International Ltd Ordinary Shares

Magnitude International Ltd is providing electrical installation services to customers in both the private and public sectors in Singapore. It includes the planning, design, material selection, installation, testing, commissioning and certification of the electrical equipment/systems to be installed. The Group's revenue is derived from Singapore.

Share on Social Networks: